NCT00596466
- Conditions
- Brain Diseases, Central Nervous System Diseases, Epilepsies, Partial, +2 more
- Locations
-
- Pfizer Investigational Site Phoenix, Arizona, United States
- Pfizer Investigational Site Fayetteville, Arkansas, United States
- Pfizer Investigational Site Fullerton, California, United States
- Pfizer Investigational Site Long Beach, California, United States